Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,540 signal articles · 206 in last 24h · 116,916 total before filter · latest 1h ago
206last 24h
1677last 7d
272● bullish (7d)
148● bearish (7d)
205publishers
AllMacro316Earnings749M&A98Regulatory25Product15Analyst25
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
BlackSky Technology (BKSY) Could Be 31% Undervalued As Strong Earnings Back Guidance
Simply Wall St.10d agoneutral
BlackSky Technology (BKSY) Could Be 31% Undervalued As Strong Earnings Back Guidance

BlackSky Technology (BKSY) stock is in focus after the company reported second quarter 2026 results that combined 50.1% year over year revenue growth, a narrower loss, and reaffirmed full year revenue guidance of US$130 million to US$150 million. See our latest analysis for BlackSky Technology. BlackSky Technology's latest earnings announcement and reaffirmed revenue guidance have coincided with a sharp rebound in the stock, with a 1-day share price return of 10.37% and 7-day share price...

Is Vertiv Holdings Co (VRT) Fully Priced Following Raised 2026 Guidance And Strong Results?
Simply Wall St.10d agoneutral
Is Vertiv Holdings Co (VRT) Fully Priced Following Raised 2026 Guidance And Strong Results?

Vertiv Holdings Co (VRT) is back in focus after raising its full year 2026 guidance and reporting higher second quarter revenue and earnings, supported by AI-focused data center demand and expanding capacity. See our latest analysis for Vertiv Holdings Co. Vertiv Holdings Co's share price has surged 56.69% year to date, with a 7 day share price return of 20.95% after its raised 2026 guidance and recent AI data center partnerships. The 1 year total shareholder return stands at 97.63%. If...

Xenon Pharmaceuticals Q2 Earnings Call Highlights
MarketBeat10d agoneutral
Xenon Pharmaceuticals Q2 Earnings Call Highlights

10x Genomics reported second-quarter revenue of $151 million, including $1.6 million in license and royalty revenue tied to its settlement with Takara Bio. Excluding non-recurring settlement revenue in both periods, revenue was $149.4 million, up 3% from the prior-year quarter. Chief Executive Offi

Wendy's Q2 Earnings Call Highlights
MarketBeat10d agoneutral
Wendy's Q2 Earnings Call Highlights

Wendy's (NASDAQ:WEN) reported weaker second-quarter results as U.S. traffic declines, pressure on franchisee economics and what new Chief Executive Officer Bob Wright described as erosion in the brand’s quality and value proposition weighed on performance. Global systemwide sales declined 6.5% on a

Warner Bros. Discovery Q2 Earnings Call Highlights
MarketBeat10d agoneutral
Warner Bros. Discovery Q2 Earnings Call Highlights

Warner Bros. Discovery (NASDAQ:WBD) said its streaming segment surpassed $3 billion in quarterly revenue for the first time in the second quarter of 2026, as HBO Max benefited from subscriber growth, engagement and advertising monetization. President and Chief Executive Officer David Zaslav said st

Datadog (DDOG) Is Down 14.6% After Mixed Q2 Beat And Cautious Q3 Guidance Has The Bull Case Changed?
Simply Wall St.10d agobullish
Datadog (DDOG) Is Down 14.6% After Mixed Q2 Beat And Cautious Q3 Guidance Has The Bull Case Changed?

In the past week, Datadog reported Q2 2026 results showing revenue rising to US$1.12 billion and net income to US$44.56 million, alongside higher full-year 2026 revenue guidance of US$4.45 billion to US$4.47 billion. At the same time, softer Q3 revenue guidance of US$1.14 billion at the midpoint and a usage reduction from its largest customer raised fresh questions about the durability of recent growth trends. We’ll now examine how Datadog’s strong quarterly results but cautious near-term...

Versant Q2 Earnings Call Highlights
MarketBeat10d agoneutral
Versant Q2 Earnings Call Highlights

Versant (NASDAQ:VSNT) reported second-quarter revenue of $1.64 billion, down 4% from the prior-year period, while adjusted EBITDA rose 3% to $624 million as growth in advertising and digital platforms helped offset continued pressure in linear television distribution. Chief Executive Officer Mark L

Jim Cramer Didn’t Think Seagate Technology Holdings plc (NASDAQ:STX)’s Earnings Were Bad
Insider Monkey10d agoneutral
Jim Cramer Didn’t Think Seagate Technology Holdings plc (NASDAQ:STX)’s Earnings Were Bad

Seagate Technology Holdings plc (NASDAQ:STX)’s shares have caught a lot of quarters, including Cramer, by surprise in today’s AI-driven era of investing. They are up by 447% over the past year and by 181% year-to-date. The CNBC TV host has discussed Seagate Technology Holdings plc (NASDAQ:STX) several times over the past couple of months. For […]